The second international standard for Lymphoblastoid Interferon, 95/568 : second evaluation studies in Japan in 2002

View/ Open
Other Titles
2nd international standard for Lymphoblastoid Interferon, 95/568Citation
World Health Organization. Biologicals Unit, Kokuritsu Kansensho Kenkyujo (Japan), Hayashibara Biochemical Laboratories, Mochida Pharmaceutical Co, Otsuka Phamaceutical Co. et al. (2003). The second international standard for Lymphoblastoid Interferon, 95/568 : second evaluation studies in Japan in 2002. Geneva : World Health Organization. http://www.who.int/iris/handle/10665/68387
Description
Discontinuity in the unitage for HulFN-N1(Human Lymphoblastoid IFN)Presented at the meeting of the Expert Committee on Biological Standardization, Geneva, 17 to 21 November 2003
WHO/BS/03.1982
14 p.
Gov't Doc #
WHO/BS/03.1982Collections
Language
EnglishMetadata
Show full item recordRelated items
Showing items related by title and MeSH subject.
-
A recommendation from the standards committee of the International Society for Interferon and Cytokine Research to adopt a standard method for the calculation and reporting of the results of interferon neutralizing antibody tests
World Health Organization. Biologicals Unit; WHO Expert Committee on Biological Standardization (2003 : Geneva, Switzerland) (WHO/BS/03.1980, 2003) -
PICO 6 treatment: (PEG-interferon vs interferon) - decision making table
World Health Organization (WHO/HIV/2014.39, 2014) -
PICO 6: treatment: pegylated interferon plus ribavirin versus standard interferon plus ribavirin for chronic hepatitis C infection: a meta-analytical systematic review
World Health Organization (WHO/HIV/2014.32, 2014)